Simmons Bank boosted its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 137.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,098 shares of the industrial products company's stock after buying an additional 13,928 shares during the period. Simmons Bank's holdings in Xylem were worth $2,879,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Xylem by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock valued at $3,323,325,000 after purchasing an additional 303,854 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Xylem by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock valued at $671,623,000 after purchasing an additional 135,492 shares in the last quarter. Royal Bank of Canada grew its position in shares of Xylem by 7.9% in the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock valued at $506,985,000 after purchasing an additional 320,500 shares in the last quarter. Invesco Ltd. grew its position in shares of Xylem by 9.8% in the fourth quarter. Invesco Ltd. now owns 4,009,907 shares of the industrial products company's stock valued at $465,229,000 after purchasing an additional 359,276 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Xylem by 8.7% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,750,377 shares of the industrial products company's stock valued at $435,119,000 after purchasing an additional 301,070 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Xylem Trading Up 0.4%
Shares of NYSE XYL traded up $0.52 during trading on Tuesday, reaching $131.52. The stock had a trading volume of 1,068,369 shares, compared to its average volume of 1,414,001. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $143.50. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.41 and a current ratio of 1.89. The business's 50-day moving average price is $126.17 and its 200-day moving average price is $122.24. The company has a market cap of $32.01 billion, a P/E ratio of 35.35, a PEG ratio of 2.41 and a beta of 1.12.
Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Tuesday, April 29th. The industrial products company reported $1.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.95 by $0.08. The firm had revenue of $2.07 billion during the quarter, compared to analyst estimates of $2.04 billion. Xylem had a return on equity of 10.12% and a net margin of 10.54%. Xylem's revenue was up 1.8% compared to the same quarter last year. During the same period last year, the business posted $0.90 earnings per share. On average, equities research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 26th. Shareholders of record on Thursday, May 29th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.22%. The ex-dividend date of this dividend was Thursday, May 29th. Xylem's payout ratio is 43.01%.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on XYL shares. Raymond James Financial upgraded Xylem to a "hold" rating in a research report on Thursday, May 15th. Royal Bank Of Canada upped their price objective on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a report on Wednesday, April 30th. JPMorgan Chase & Co. started coverage on Xylem in a report on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective on the stock. Citigroup decreased their price objective on Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Finally, Robert W. Baird decreased their price objective on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a report on Wednesday, April 30th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, Xylem currently has a consensus rating of "Moderate Buy" and an average price target of $143.71.
View Our Latest Stock Report on XYL
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.